首页> 外文期刊>Journal of the South Carolina Academy of Science >Investigation of Moringa oleifera leaf extract and its cancer-selective antiproliferative properties
【24h】

Investigation of Moringa oleifera leaf extract and its cancer-selective antiproliferative properties

机译:辣木叶提取物及其抗癌增生特性的研究

获取原文
           

摘要

Moringa oleifera is a tree native to a number of Asian, African, and Central American countries and has been used in traditional medicine for an assortment of medicinal uses for centuries. Due to bioactive compounds within Moringa leaves, it is believed that Moringa leaf extract may possess cancer-selective antiproliferative properties. Previous research has been conducted in regards to this topic, but poor experimental design due to lack of necessary controls limits the legitimacy of anticancer claims. While previous research has shown that Moringa leaf extract has the potential to kill cancer cells, the research fails to demonstrate the effects of Moringa leaf extract on healthy cells. In order for anticancer claims to be sufficient and yield the possibility of a future cancer treatment, Moringa leaf extract must not harm non-cancerous cells. This is essential in order to be considered a cancer-selective killing agent. The current study was designed using tissue type pairs including both cancerous and non-cancerous cell lines. These cell lines were treated with increasing concentrations of Moringa leaf extracts. After 48 hours, cell proliferation was measured with CellTiter 96 Aqueous Non-Radioactive Cell Proliferation Assay, and statistical analyses were completed. Results showed that the Moringa leaf extract had no statistically significant effect on either of the breast cell lines, cancerous or non-cancerous. However, the results suggest there is a statistically significant difference in cell proliferation between the lung cell lines. Low concentrations increased cell proliferation in the healthy lung cells while having no significant effect on the cancerous lung cells. The effects reversed at higher concentrations. This could be due to the difference in cell responses between cancerous lung cells and healthy lung cells. Microscopy findings provided qualitative results that helped determine the method of cell death occurring by cells treated with Moringa leaf extract. Ideally, an effective cancer treatment would cause cancerous cells to die by apoptosis, rather than necrosis. However, the findings suggest necrosis is the primary mode of death occurring in the cancerous lung cells, while the cancerous breast cells showed no signs of cell death. This research contradicts previous findings that Moringa leaf extract is a cancer killing agent; therefore, more research should be completed to understand these new findings.
机译:辣木是许多亚洲,非洲和中美洲国家的本地树种,数百年来一直用于传统医学中,用于各种医学用途。由于辣木叶中具有生物活性化合物,因此认为辣木叶提取物可能具有癌症选择性的抗增殖特性。关于该主题已经进行了先前的研究,但是由于缺乏必要的控制而导致的较差的实验设计限制了抗癌声称的合法性。尽管先前的研究表明辣木叶提取物具有杀死癌细胞的潜力,但该研究未能证明辣木叶提取物对健康细胞的作用。为了使抗癌药声称足够并产生将来进行癌症治疗的可能性,辣木叶提取物一定不能伤害非癌细胞。为了被认为是癌症选择性杀伤剂,这是必不可少的。本研究是使用包括癌细胞和非癌细胞系的组织类型对设计的。这些细胞系用浓度不断增加的辣木叶提取物处理。 48小时后,用CellTiter 96非放射性细胞水增殖测定法测量细胞增殖,并完成统计分析。结果显示,辣木叶提取物对癌性或非癌性乳腺细胞系均无统计学意义。但是,结果表明,肺细胞系之间的细胞增殖存在统计学上的显着差异。低浓度增加了健康肺细胞中的细胞增殖,而对癌性肺细胞没有显着影响。在较高浓度下效果相反。这可能是由于癌性肺细胞和健康肺细胞之间的细胞反应差异所致。显微镜检查结果提供了定性结果,有助于确定用辣木叶提取物处理的细胞发生的细胞死亡方法。理想地,有效的癌症治疗将导致癌细胞通过凋亡而不是坏死而死亡。但是,发现提示坏死是发生在肺癌肺细胞中的主要死亡方式,而癌性乳腺癌细胞则没有细胞死亡的迹象。这项研究与辣木叶提取物是一种癌症杀灭剂的先前发现相矛盾。因此,应完成更多的研究以了解这些新发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号